• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

As California’s COVID cases rise, antibody treatments go unused

Emily

Editor, Senior Moderator
https://www.mercurynews.com/2021/12/...nts-go-unused/
As California’s COVID cases rise, antibody treatments go unused

Instant immunization isn’t getting to the people who need it.
By Lisa M. Krieger | lkrieger@bayareanewsgroup.com | Bay Area News Group
PUBLISHED: December 12, 2021 at 5:50 a.m. | UPDATED: December 14, 2021 at 5:14 a.m.

The number of Californians hospitalized for COVID-19 is once again climbing — even as a powerful treatment goes unused.
Deployment of the free, life-saving monoclonal antibody therapy, which reduces the risk of hospitalization by 80%, has been slowed due to poor communication and administrative coordination, as well as a shortage of facilities equipped to provide the infusion. In some cases, patients may not be aware of the treatment or may be hesitant to use it.
“It’s not getting to people,” said Dr. Peter Chin-Hong, professor of medicine and an infectious disease specialist at UC San Francisco. “We have this tool that we’re not using.”..
 
Back
Top